I agree that this site is using cookies. You can find further informations here.
X
Parikh, Apurvasena
28  results:
Search for persons X
?
1

Dose Optimization in Oncology Drug Development: An Internat..:

Samineni, Divya ; Venkatakrishnan, Karthik ; Othman, Ahmed A....
Clinical Pharmacology & Therapeutics.  , 2024
Link: https://doi.org/10.1002/..
 
?
2

A Phase 1b Study of Telisotuzumab Vedotin in Combination Wi..:

Camidge, D. Ross ; Barlesi, Fabrice ; Goldman, Jonathan W....
JTO Clinical and Research Reports.  3 (2022)  1 - p. 100262 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Phase 1 study of telisotuzumab vedotin in Japanese patients..:

Fujiwara, Yutaka ; Kenmotsu, Hirotsugu ; Yamamoto, Noboru...
Cancer Medicine.  10 (2021)  7 - p. 2350-2358 , 2021
Link: https://doi.org/10.1002/..
 
?
4

Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedot..:

Camidge, D. Ross ; Morgensztern, Daniel ; Heist, Rebecca S....
Clinical Cancer Research.  27 (2021)  21 - p. 5781-5792 , 2021
Link: https://doi.org/10.1158/..
 
?
5

First-in-human phase 1 study of budigalimab, an anti-PD-1 i..:

Italiano, Antoine ; Cassier, Philippe A. ; Lin, Chia-Chi...
Cancer Immunology, Immunotherapy.  71 (2021)  2 - p. 417-431 , 2021
Link: https://doi.org/10.1007/..
 
?
6

Safety, pharmacokinetics, and efficacy of budigalimab with ..:

Calvo, Emiliano ; Spira, Alexander ; Miguel, María de...
Cancer Treatment and Research Communications.  28 (2021)  - p. 100405 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Model Informed Dosing Regimen and Phase I Results of the An..:

Powderly, John ; Spira, Alexander ; Kondo, Shunsuke...
Clinical and Translational Science.  14 (2020)  1 - p. 277-287 , 2020
Link: https://doi.org/10.1111/..
 
?
8

Assessment of Clinical Drug‐Drug Interactions of Elagolix, ..:

Polepally, Akshanth R. ; Ng, Juki W. ; Salem, Ahmed Hamed...
The Journal of Clinical Pharmacology.  60 (2020)  12 - p. 1606-1616 , 2020
Link: https://doi.org/10.1002/..
 
?
9

Are Clinical Therapeutic Protein‐Drug Interaction Studies N..:

Pang, Yinuo ; Rosebraugh, Matthew R. ; Freise, Kevin J...
The Journal of Clinical Pharmacology.  58 (2018)  10 - p. 1371-1372 , 2018
Link: https://doi.org/10.1002/..
 
?
10

Industry Perspective on Standardizing Food-Effect Studies f..:

Marroum, Patrick J. ; Nuthalapati, Silpa ; Parikh, Apurvasena...
Clinical Pharmacokinetics.  57 (2018)  8 - p. 901-909 , 2018
Link: https://doi.org/10.1007/..
 
?
11

An Innovative Approach to Proactively Evaluate and Update D..:

Porcalla, Ariel ; Barshteyn, Nella ; Valdes, Joaquin...
Open Forum Infectious Diseases.  2 (2015)  suppl_1 - p. , 2015
Link: https://doi.org/10.1093/..
 
?
12

Crystallographic analysis of human hemoglobin elucidates th..:

Abdulmalik, Osheiza ; Ghatge, Mohini S. ; Musayev, Faik N....
Acta Crystallographica Section D Biological Crystallography.  67 (2011)  11 - p. 920-928 , 2011
Link: https://doi.org/10.1107/..
 
?
13

Crystallographic analysis of human hemoglobin elucidates th..:

Abdulmalik, Osheiza ; Ghatge, Mohini S. ; Musayev, Faik N....
Acta Crystallographica Section D Biological Crystallography.  67 (2011)  12 - p. 1076-1076 , 2011
Link: https://doi.org/10.1107/..
 
?
14

First-in-human phase 1 study of budigalimab, an anti-PD-1 i..:

Italiano, Antoine ; Cassier, Philippe A ; Lin, Chia-Chi...
10.1007/s00262-021-02973-w.  , 2023
Link: http://hdl.handle.net/10..
 
?
15

Phase Ib Study of Telisotuzumab Vedotin in Combination With..:

Camidge, D. Ross ; Barlesi, Fabrice ; Goldman, Jonathan W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928626/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15